|
KR20190133017A
(ko)
*
|
2017-03-27 |
2019-11-29 |
에프. 호프만-라 로슈 아게 |
개선된 항원 결합 수용체 구성
|
|
CN110526987A
(zh)
*
|
2018-05-25 |
2019-12-03 |
深圳宾德生物技术有限公司 |
靶向cd133的嵌合抗原受体、嵌合抗原受体t细胞及其制备方法和应用
|
|
CN109735500B
(zh)
*
|
2019-01-25 |
2023-05-16 |
苏州茂行生物科技有限公司 |
一种分泌型靶向cd133的car-t细胞及其制备方法和应用
|
|
WO2020232247A1
(en)
|
2019-05-14 |
2020-11-19 |
Provention Bio, Inc. |
Methods and compositions for preventing type 1 diabetes
|
|
GB2599814A
(en)
|
2019-05-31 |
2022-04-13 |
Univ Johns Hopkins |
Bispecific binding agents
|
|
US20220251222A1
(en)
*
|
2019-05-31 |
2022-08-11 |
The Johns Hopkins University |
IL-6Ralpha/IL-8R BISPECIFIC BINDING AGENTS FOR INHIBITING CANCER CELL MIGRATION
|
|
CN113912697B
(zh)
*
|
2019-07-24 |
2023-05-30 |
暨南大学 |
靶向cd133的结合蛋白与应用
|
|
IL298999A
(en)
|
2020-06-11 |
2023-02-01 |
Provention Bio Inc |
Methods and compositions for the prevention of type 1 diabetes
|
|
CN111529690B
(zh)
*
|
2020-06-17 |
2023-03-31 |
中国科学院昆明动物研究所 |
人cd133蛋白1-108肽段的新用途
|
|
CN114057875B
(zh)
*
|
2020-07-31 |
2023-05-05 |
北京市神经外科研究所 |
抗cd133的单链抗体及其在制备治疗肿瘤的药物中的用途
|
|
WO2022067005A1
(en)
*
|
2020-09-27 |
2022-03-31 |
Genentech, Inc. |
High throughput multiparametric immune cell engager screening assay
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
KR20230118887A
(ko)
|
2020-12-03 |
2023-08-14 |
센츄리 쎄라퓨틱스 인코포레이티드 |
유전자 조작 세포 및 이의 용도
|
|
AR124414A1
(es)
|
2020-12-18 |
2023-03-22 |
Century Therapeutics Inc |
Sistema de receptor de antígeno quimérico con especificidad de receptor adaptable
|
|
KR20230122618A
(ko)
|
2020-12-21 |
2023-08-22 |
알로젠 테라퓨틱스 인코포레이티드 |
프로테아제 활성화 cd45-게이트 car
|
|
CA3204417A1
(en)
|
2021-01-29 |
2022-08-04 |
Allogene Therapeutics, Inc. |
Knockdown or knockout of one or more of tap2, nlrc5, ?2m, trac, rfx5, rfxap and rfxank to mitigate t cell recognition of allogeneic cell products
|
|
JP2024520444A
(ja)
|
2021-05-24 |
2024-05-24 |
プロヴェンション・バイオ・インコーポレイテッド |
１型糖尿病を治療するための方法
|
|
JP2024520666A
(ja)
*
|
2021-06-04 |
2024-05-24 |
アムジェン リサーチ （ミュニック） ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｔ細胞エンゲージャ分子及びその使用
|
|
CN114316050B
(zh)
*
|
2021-12-24 |
2022-11-11 |
北京市神经外科研究所 |
Cd133抗体、嵌合抗原受体及其应用
|
|
CN114213537B
(zh)
*
|
2021-12-24 |
2022-06-14 |
北京市神经外科研究所 |
Cd133抗体、嵌合抗原受体及其应用
|
|
EP4463135A2
(en)
|
2022-01-10 |
2024-11-20 |
Sana Biotechnology, Inc. |
Methods of ex vivo dosing and administration of lipid particles or viral vectors and related systems and uses
|
|
CA3261440A1
(en)
|
2022-07-29 |
2024-02-01 |
Allogene Therapeutics, Inc. |
MODIFIED CELLS WITH REDUCED GENE EXPRESSION TO MITIGATE RECOGNITION BY IMMUNE CELLS
|
|
WO2024040194A1
(en)
|
2022-08-17 |
2024-02-22 |
Capstan Therapeutics, Inc. |
Conditioning for in vivo immune cell engineering
|
|
WO2024081820A1
(en)
|
2022-10-13 |
2024-04-18 |
Sana Biotechnology, Inc. |
Viral particles targeting hematopoietic stem cells
|
|
WO2024119157A1
(en)
|
2022-12-02 |
2024-06-06 |
Sana Biotechnology, Inc. |
Lipid particles with cofusogens and methods of producing and using the same
|
|
WO2024220597A2
(en)
|
2023-04-18 |
2024-10-24 |
Sana Biotechnology, Inc. |
Digital droplet based assay for detecting replication competent lentiviral vector
|
|
EP4716750A1
(en)
|
2023-05-23 |
2026-04-01 |
Sana Biotechnology, Inc. |
Tandem fusogens and related lipid particles
|
|
AU2024279278A1
(en)
|
2023-05-31 |
2025-12-18 |
Capstan Therapeutics, Inc. |
Lipid nanoparticle formulations and compositions
|
|
WO2025056957A1
(en)
*
|
2023-09-15 |
2025-03-20 |
Jimenez Mendoza, Dimas |
Peptide based medicines for treating cancer
|
|
WO2025076113A1
(en)
|
2023-10-05 |
2025-04-10 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids with conserved spacing and lipid nanoparticles
|
|
US20250127728A1
(en)
|
2023-10-05 |
2025-04-24 |
Capstan Therapeutics, Inc. |
Constrained Ionizable Cationic Lipids and Lipid Nanoparticles
|
|
AU2024372734A1
(en)
|
2023-10-30 |
2026-04-16 |
Allogene Therapeutics, Inc. |
Engineered cells
|
|
WO2025184529A1
(en)
|
2024-03-01 |
2025-09-04 |
Sana Biotechnology, Inc. |
Viral particles with fusogen display and related compositions and methods
|
|
WO2025217452A1
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Constrained ionizable cationic lipids and lipid nanoparticles
|
|
WO2025217454A2
(en)
|
2024-04-11 |
2025-10-16 |
Capstan Therapeutics, Inc. |
Ionizable cationic lipids and lipid nanoparticles
|
|
CN118108849B
(zh)
*
|
2024-04-28 |
2024-06-25 |
苏州睿瀛生物技术有限公司 |
一种抗cd33的纳米抗体制备方法和抗体的荧光标记流式应用
|